The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations
Open Access
- 20 August 2009
- journal article
- research article
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 256
Abstract
Background: A major challenge in computational biology is to extract knowledge about the genetic nature of disease from high-throughput data. However, an important obstacle to both biological understanding and clinical applications is the "black box" nature of the decision rules provided by most machine learning approaches, which usually involve many genes combined in a highly complex fashion. Achieving biologically relevant results argues for a different strategy. A promising alternative is to base prediction entirely upon the relative expression ordering of a small number of genes.Results: We present a three-gene version of "relative expression analysis" (RXA), a rigorous and systematic comparison with earlier approaches in a variety of cancer studies, a clinically relevant application to predicting germline BRCA1 mutations in breast cancer and a cross-study validation for predicting ER status. In the BRCA1 study,RXAyields high accuracy with a simple decision rule: in tumors carrying mutations, the expression of a "reference gene" falls between the expression of two differentially expressed genes,PPP1CBandRNF14. An analysis of the protein-protein interactions among the triplet of genes andBRCA1 suggests that the classifier has a biological foundation.Conclusion: RXAhas the potential to identify genomic "marker interactions" with plausible biological interpretation and direct clinical applicability. It provides a general framework for understanding the roles of the genes involved in decision rules, as illustrated for the difficult and clinically relevant problem of identifyingBRCA1 mutation carriers.Keywords
This publication has 45 references indexed in Scilit:
- Pre-processing Agilent microarray dataBMC Bioinformatics, 2007
- Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomasProceedings of the National Academy of Sciences, 2007
- Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast CancerJAMA, 2006
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences, 2005
- Human protein reference database as a discovery resource for proteomicsNucleic Acids Research, 2004
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI: Journal of the National Cancer Institute, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998